SCHEMBL13890895

SCHEMBL13890895

Nc1cc(N2CCc3ccccc32)ccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
KDM4C Q9H3R0 5/20 0.46
KDM6B O15054 1/20 0.43
ALDH1A1 P00352 6/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 3/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 4/20 0.43
PKM P14618 1/20 0.43
IP6K1 Q92551 1/20 0.41
NOTUM Q6P988 1/20 0.41
IDO1 P14902 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14428223 0.82 KDM4C (0.49) NPC1RAB9AL3MBTL1KDM4CKDM6B
SCHEMBL4211178 0.81 NPC1 (0.41) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL13890893 0.81 ALDH1A1 (0.52) NPC1RAB9AL3MBTL1KDM4CALDH1A1
SCHEMBL4220968 0.81 KDM4C (0.51) NPC1RAB9AKDM4CKDM6BALDH1A1
SCHEMBL2269025 0.79 MAPT (0.50) KDM4CKDM6BALDH1A1MEN1KMT2A
SCHEMBL22442390 0.78 ALDH1A1 (0.53) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL29784320 0.78 ALDH1A1 (0.53) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL28218556 0.78 TSHR (0.43) NPC1RAB9AL3MBTL1KDM4CALDH1A1
SCHEMBL6715699 0.77 NPC1 (0.53) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL10639671 0.77 ALDH1A1 (0.58) NPC1RAB9AL3MBTL1KDM4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 NPC1 4833/4885RAB9A 2262/4885L3MBTL1 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.